Joseph Palumbo
Directeur Technique/Scientifique/R&D chez BIOVIE INC.
Fortune : 3 633 $ au 30/04/2024
Postes actifs de Joseph Palumbo
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| BIOVIE INC. | Directeur Technique/Scientifique/R&D | 01/11/2021 | - |
| HYDREIGHT TECHNOLOGIES INC. | Directeur/Membre du Conseil | 25/11/2022 | - |
Historique de carrière de Joseph Palumbo
Anciens postes connus de Joseph Palumbo
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ZYNERBA PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/07/2019 | 01/10/2021 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | - | - |
| MITSUBISHI TANABE PHARMA CORPORATION | Corporate Officer/Principal | - | - |
Formation de Joseph Palumbo
| University of Pennsylvania Graduate School of Education | Undergraduate Degree |
| George Washington University School of Medicine & Health | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
| Japon | 2 |
| Canada | 2 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 3 |
| Retail Trade | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| ZYNERBA PHARMACEUTICALS, INC. | Health Technology |
| BIOVIE INC. | Health Technology |
| HYDREIGHT TECHNOLOGIES INC. | Retail Trade |
| Entreprise privées | 1 |
|---|---|
Mitsubishi Tanabe Pharma Corp.
 Mitsubishi Tanabe Pharma Corp. Pharmaceuticals: OtherHealth Technology Mitsubishi Tanabe Pharma Corp. engages in the research, development, manufacture, and sale of pharmaceutical products. Its products include Remicade, Ceredist, Talion, Kremezin, Maintate, Simponi, Lexapro, Tenelia, Tetrabik, and Imusera. The company was founded by Gohei Tanabeya in 1678 and is headquartered in Osaka, Japan. | Health Technology |
- Bourse
- Insiders
- Joseph Palumbo
- Expérience
